FDA Moving Forward on a Regulatory Pathway for CBD and Seeking Guidance from Industry

Opportunity for Greenspoon Marder Clients to Testify at FDA Hearing or Submit Written Comments to Inform FDA on Key Issues for Establishing CBD Regulations FDA has been moving, since the December 20, 2018 passage of the 2018 Farm Bill, toward the full legal recognition of hemp-derived CBD as a food additive and dietary supplement and recently announced that it will be holding a public hearing on products, such as hemp derived CBD, on May 31, 2019, from 8 a.m. to 6 p.m. FDA is currently accepting requests for presentations during the public hearing and is accepting written comments through July 2, 2019. This is a critical opportunity to inform FDA before it issues regulations or moves forward to regulate CBD. The hearing will be a major gathering of CBD companies in the Washington DC area to testify for a full day at FDA headquarters before a panel of high-level FDA officials. The public hearing will give stakeholders an opportunity to provide the agency with…

Read more detail on Recent Business Law posts –

This entry was posted in Business law and tagged , , , , , , . Bookmark the permalink.

Leave a Reply